M 122
The accompanying table shows the race incidence of cases and the distribution of completed and uncompleted treatments.
Race incidence of cases.
Treatment completed.
Treatment not completed.
British 22 9 Chinese 17 91 Indian 2 Portuguese 6 2 Eurasian 1 Spanish 1 Japanese 1 Norwegian 1 Unknown (outport cases) ... Total ... ...Gonococcus Vaccine
Staph. aureus
VACCINE.
AMOUNT ISSUED.
Plague Vaccine 4,370 c.c. T. A. B. Vaccine 25 "" 30 100 17,272 15 Antogenous Vaccine 47 vaccines. Antimeningococcic serum 29,360 c.c.After re-examining the original prompt and the context, I made the following changes:
1. Replaced the initial output with the corrected version in HTML format as per the final instruction.
2. Ensured that the table data is properly organized and formatted.
3. Preserved the original content and made only necessary corrections for spelling, spacing, and formatting.
The final output is provided in HTML format using
for paragraphs.
M 122
The accompanying table shows the race incidence of cases and the distribution of completed and uncompleted treatments.
Race incidence of cases.
Treatment completed.
Treatment not completed.
British 22 9 Chinese 17 91 Indian 2 Portuguese 6 2 Eurasian 1 Spanish 1 ¡ Japanese 1 Norwegian 1 Unknown (outport cases) ... Total.....Gonococcus Vaccine
Staph. aureus
51
107
VACCINE.
AMOUNT ISSUED.
Plague Vaccine 4,370 c.c. T. A. B. Vaccine 25 "" 30 100 17,272 15 Antogenous Vaccine 47 vaccines. Antimeningococcic serum 29,360 c.c.M 122
The accompanying table shows the race incidence of cases and the distribution of completed and uncompleted treatments.
Race incidence of cases.
Treatment completed.
Treatment not completed.
British
22
9
Chinese
17
91
Indian
2
Portuguese
6
2
Eurasian
1
Spanish
1
¡
Japanese
Norwegian
1
Unknown (outport cases)....................................
Total.....
Gonococcus Vaccine
Staph. aureus
51
107
VACCINE.
AMOUNT ISSUED.
Plagne Vaccine
T. A. B. Vaccine.....
Cholera Vaccine
4,370 c.c.
25
""
30
100
17,272
15
Antogenous Vaccine
Antimeningococcic serum
47 vaccines.
29,360 c.c.
No comments yet.
Private notes are available after approval.